Johnson & Johnson (JNJ) Competitors $174.46 +0.04 (+0.02%) As of 12:01 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock JNJ vs. ISRG, MRNA, NVAX, ABBV, BRK.B, LLY, MRK, PFE, PG, and XOMShould you be buying Johnson & Johnson stock or one of its competitors? The main competitors of Johnson & Johnson include Intuitive Surgical (ISRG), Moderna (MRNA), Novavax (NVAX), AbbVie (ABBV), Berkshire Hathaway (BRK.B), Eli Lilly and Company (LLY), Merck & Co., Inc. (MRK), Pfizer (PFE), Procter & Gamble (PG), and Exxon Mobil (XOM). Johnson & Johnson vs. Its Competitors Intuitive Surgical Moderna Novavax AbbVie Berkshire Hathaway Eli Lilly and Company Merck & Co., Inc. Pfizer Procter & Gamble Exxon Mobil Johnson & Johnson (NYSE:JNJ) and Intuitive Surgical (NASDAQ:ISRG) are both large-cap medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their institutional ownership, risk, valuation, dividends, analyst recommendations, profitability, media sentiment and earnings. Which has higher valuation and earnings, JNJ or ISRG? Johnson & Johnson has higher revenue and earnings than Intuitive Surgical. Johnson & Johnson is trading at a lower price-to-earnings ratio than Intuitive Surgical, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioJohnson & Johnson$88.82B4.73$14.07B$9.3518.66Intuitive Surgical$8.35B20.41$2.32B$7.1766.32 Which has more risk & volatility, JNJ or ISRG? Johnson & Johnson has a beta of 0.41, suggesting that its share price is 59% less volatile than the S&P 500. Comparatively, Intuitive Surgical has a beta of 1.59, suggesting that its share price is 59% more volatile than the S&P 500. Do institutionals and insiders have more ownership in JNJ or ISRG? 69.6% of Johnson & Johnson shares are held by institutional investors. Comparatively, 83.6% of Intuitive Surgical shares are held by institutional investors. 0.2% of Johnson & Johnson shares are held by company insiders. Comparatively, 0.7% of Intuitive Surgical shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth. Is JNJ or ISRG more profitable? Intuitive Surgical has a net margin of 28.51% compared to Johnson & Johnson's net margin of 25.00%. Johnson & Johnson's return on equity of 32.49% beat Intuitive Surgical's return on equity.Company Net Margins Return on Equity Return on Assets Johnson & Johnson25.00% 32.49% 13.00% Intuitive Surgical 28.51%14.56%12.93% Do analysts rate JNJ or ISRG? Johnson & Johnson presently has a consensus target price of $174.50, indicating a potential upside of 0.02%. Intuitive Surgical has a consensus target price of $595.95, indicating a potential upside of 25.34%. Given Intuitive Surgical's higher probable upside, analysts clearly believe Intuitive Surgical is more favorable than Johnson & Johnson.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Johnson & Johnson 0 Sell rating(s) 9 Hold rating(s) 9 Buy rating(s) 2 Strong Buy rating(s) 2.65Intuitive Surgical 1 Sell rating(s) 5 Hold rating(s) 13 Buy rating(s) 0 Strong Buy rating(s) 2.63 Does the media refer more to JNJ or ISRG? In the previous week, Johnson & Johnson had 35 more articles in the media than Intuitive Surgical. MarketBeat recorded 90 mentions for Johnson & Johnson and 55 mentions for Intuitive Surgical. Johnson & Johnson's average media sentiment score of 1.57 beat Intuitive Surgical's score of 1.51 indicating that Johnson & Johnson is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Johnson & Johnson 84 Very Positive mention(s) 1 Positive mention(s) 3 Neutral mention(s) 2 Negative mention(s) 0 Very Negative mention(s) Very Positive Intuitive Surgical 50 Very Positive mention(s) 1 Positive mention(s) 2 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Very Positive SummaryJohnson & Johnson beats Intuitive Surgical on 9 of the 17 factors compared between the two stocks. Get Johnson & Johnson News Delivered to You Automatically Sign up to receive the latest news and ratings for JNJ and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding JNJ and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart JNJ vs. The Competition Export to ExcelMetricJohnson & JohnsonLarge Cap Pharma IndustryMedical SectorNYSE ExchangeMarket Cap$420.20B$240.23B$5.58B$20.89BDividend Yield3.01%2.98%4.62%3.61%P/E Ratio18.6629.5730.2628.20Price / Sales4.734.68446.9779.29Price / Cash13.1712.5337.7523.46Price / Book5.357.108.405.35Net Income$14.07B$8.49B$3.25B$994.60M7 Day Performance1.78%3.88%3.50%2.01%1 Month Performance11.18%-2.71%3.86%0.91%1 Year Performance10.10%-9.22%35.40%15.19% Johnson & Johnson Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)JNJJohnson & Johnson4.7233 of 5 stars$174.46+0.0%$174.50+0.0%+10.0%$420.20B$88.82B18.66138,100Positive NewsISRGIntuitive Surgical4.8051 of 5 stars$471.09+0.2%$595.95+26.5%+2.8%$168.86B$8.35B65.7015,638Positive NewsMRNAModerna4.4638 of 5 stars$25.64-1.9%$43.59+70.0%-67.6%$9.94B$3.24B-3.395,800NVAXNovavax4.7495 of 5 stars$7.94-5.2%$15.86+99.8%-27.2%$1.29B$1.08B3.471,990Analyst RevisionABBVAbbVie4.7457 of 5 stars$197.83-0.1%$214.43+8.4%+5.3%$349.02B$56.33B94.0855,000Trending NewsAnalyst ForecastBRK.BBerkshire Hathaway1.8346 of 5 stars$464.62-0.2%$575.00+23.8%+10.4%$1.00T$371.43B15.92392,400LLYEli Lilly and Company4.9993 of 5 stars$643.44+2.8%$977.65+51.9%-27.3%$609.38B$53.26B42.0247,000Trending NewsEarnings ReportAnalyst ForecastInsider TradeHigh Trading VolumeMRKMerck & Co., Inc.4.9956 of 5 stars$79.97-0.9%$107.44+34.4%-27.7%$199.62B$64.17B12.3175,000Positive NewsPFEPfizer4.9912 of 5 stars$24.68+0.4%$28.12+14.0%-12.9%$140.23B$63.83B13.1281,000Trending NewsPGProcter & Gamble4.7257 of 5 stars$155.20+1.1%$175.88+13.3%-7.1%$363.54B$84.28B23.84109,000Positive NewsAnalyst RevisionXOMExxon Mobil4.8347 of 5 stars$105.91-0.8%$125.26+18.3%-8.8%$451.40B$349.59B15.0461,000Positive News Related Companies and Tools Related Companies Intuitive Surgical Competitors Moderna Competitors Novavax Competitors AbbVie Competitors Berkshire Hathaway Competitors Eli Lilly and Company Competitors Merck & Co., Inc. Competitors Pfizer Competitors Procter & Gamble Competitors Exxon Mobil Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NYSE:JNJ) was last updated on 8/14/2025 by MarketBeat.com Staff From Our PartnersGenerate up to $5,000/month with 10X less money?The secret to retiring without a million-dollar nest egg. I'm talking about generating enough monthly inco...Investors Alley | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredTesla is in troubleThis company is the lifeblood of AI data centers, yet almost no one has caught up with the story. Their hardwa...InvestorPlace | SponsoredHe Called Nvidia at $1.10. Now, He Says THIS Stock Will…The original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvi...The Oxford Club | SponsoredBREAKING: The House just passed 3 pro-crypto bills!THREE pro-crypto bills just passed the House! Now, experts believe altcoin season is officially here. Crypto 101 Media | SponsoredNational 'Stock Market Reset' Coming September 30 (New WH Order)Crash Coming Sept 30? Analysts Warn of New Crisis A new problem on the U.S. power grid is putting millions ...Altimetry | SponsoredWhen the levee breaksThe U.S. Treasury just confirmed it plans to borrow $1.01 trillion this quarter—nearly double what was project...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Johnson & Johnson Please log in to your account or sign up in order to add this asset to your watchlist. Share Johnson & Johnson With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.